Search
for
Sort by
Research 121–150 of 1000+
- The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men
- Association of ACE2, Insulin Resistance, and Other Parameters in Obese Polycystic Ovary Syndrome Patients Infected with COVID-19
- POLYCYSTIC OVARY SYNDROME: DIVERSE CLINICAL PRESENTATIONS ACROSS ADOLESCENCE, REPRODUCTIVE AGE, AND MENOPAUSE
- A Study on the Pattern of Genetic Inheritance of Polycystic Ovarian Syndrome
- The Polycystic Ovary Syndrome - Challenges and Opportunities in Adolescent Medicine
- Quantitative evaluation of carcinosin as an individualized remedy in pediatric alopecia areata using salt score and ludwig hair loss scales: A case report
- Trichilemmal Carcinoma of the Thigh
- Síndrome PRIDE: una práctica forma de identificar los efectos adversos cutáneos de los inhibidores del EGFR
- Clinical aspects of the metabolic syndrome
- Oncogenes and morphogens: intricacies of targeted therapy in cutaneous basal cell carcinoma
- Scleroderma and L-tryptophan: A possible explanation of the eosinophilia-myalgia syndrome
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Basal Cell Carcinoma, Hedgehog Signaling, and Targeted Therapeutics: The Long and Winding Road
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- What may be the markers of the male equivalent of polycystic ovary syndrome?
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome
- Managing Polycystic Ovary Syndrome: A Cognitive Behavioral Strategy
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Pharmacologic Treatment of Polycystic Ovary Syndrome